Neurobiology of schizophrenia - PubMed
- ️Sun Jan 01 2006
Review
. 2006 Oct 5;52(1):139-53.
doi: 10.1016/j.neuron.2006.09.015.
Affiliations
- PMID: 17015232
- DOI: 10.1016/j.neuron.2006.09.015
Free article
Review
Neurobiology of schizophrenia
Christopher A Ross et al. Neuron. 2006.
Free article
Abstract
With its hallucinations, delusions, thought disorder, and cognitive deficits, schizophrenia affects the most basic human processes of perception, emotion, and judgment. Evidence increasingly suggests that schizophrenia is a subtle disorder of brain development and plasticity. Genetic studies are beginning to identify proteins of candidate genetic risk factors for schizophrenia, including dysbindin, neuregulin 1, DAOA, COMT, and DISC1, and neurobiological studies of the normal and variant forms of these genes are now well justified. We suggest that DISC1 may offer especially valuable insights. Mechanistic studies of the properties of these candidate genes and their protein products should clarify the molecular, cellular, and systems-level pathogenesis of schizophrenia. This can help redefine the schizophrenia phenotype and shed light on the relationship between schizophrenia and other major psychiatric disorders. Understanding these basic pathologic processes may yield novel targets for the development of more effective treatments.
Similar articles
-
Owen MJ, Craddock N, O'Donovan MC. Owen MJ, et al. Trends Genet. 2005 Sep;21(9):518-25. doi: 10.1016/j.tig.2005.06.011. Trends Genet. 2005. PMID: 16009449 Review.
-
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.
Harrison PJ, Weinberger DR. Harrison PJ, et al. Mol Psychiatry. 2005 Jan;10(1):40-68; image 5. doi: 10.1038/sj.mp.4001558. Mol Psychiatry. 2005. PMID: 15263907 Review.
-
Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses.
Sawamura N, Sawa A. Sawamura N, et al. Ann N Y Acad Sci. 2006 Nov;1086:126-33. doi: 10.1196/annals.1377.018. Ann N Y Acad Sci. 2006. PMID: 17185511 Review.
-
Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?
Scolnick EM, Petryshen T, Sklar P. Scolnick EM, et al. Harv Rev Psychiatry. 2006 Mar-Apr;14(2):64-77. doi: 10.1080/10673220600642960. Harv Rev Psychiatry. 2006. PMID: 16603473 Review.
-
Roffman JL, Weiss AP, Goff DC, Rauch SL, Weinberger DR. Roffman JL, et al. Harv Rev Psychiatry. 2006 Mar-Apr;14(2):78-91. doi: 10.1080/10673220600642945. Harv Rev Psychiatry. 2006. PMID: 16603474 Review.
Cited by
-
Lee H, Joo J, Nah SS, Kim JW, Kim HK, Kwon JT, Lee HY, Kim YO, Kim HJ. Lee H, et al. Int J Mol Med. 2015 Jun;35(6):1574-86. doi: 10.3892/ijmm.2015.2161. Epub 2015 Apr 1. Int J Mol Med. 2015. PMID: 25847191 Free PMC article. Clinical Trial.
-
Altered expression of the DISC1 gene in peripheral blood of patients with schizophrenia.
Fu X, Zhang G, Liu Y, Zhang L, Zhang F, Zhou C. Fu X, et al. BMC Med Genet. 2020 Oct 2;21(1):194. doi: 10.1186/s12881-020-01132-9. BMC Med Genet. 2020. PMID: 33008326 Free PMC article.
-
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.
Basso V, Döbrössy MD, Thompson LH, Kirik D, Fuller HR, Gates MA. Basso V, et al. Biology (Basel). 2024 Sep 3;13(9):690. doi: 10.3390/biology13090690. Biology (Basel). 2024. PMID: 39336117 Free PMC article. Review.
-
Metabolism of the neuromodulator D-serine.
Pollegioni L, Sacchi S. Pollegioni L, et al. Cell Mol Life Sci. 2010 Jul;67(14):2387-404. doi: 10.1007/s00018-010-0307-9. Epub 2010 Mar 2. Cell Mol Life Sci. 2010. PMID: 20195697 Free PMC article. Review.
-
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.
Balu DT, Coyle JT. Balu DT, et al. Neurosci Biobehav Rev. 2011 Jan;35(3):848-70. doi: 10.1016/j.neubiorev.2010.10.005. Epub 2010 Oct 15. Neurosci Biobehav Rev. 2011. PMID: 20951727 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous